Biologics, Proteins, Vaccines
Online Exclusives
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
RevolKa and La Jolla Institute Partner to Create Antigens for Next-Gen Vaccines
Aim to address unmet medical needs in infectious diseases.04.19.24
-
Biologics, Proteins, Vaccines
Needle-Free Vaccines: Leading Innovation in Drug Delivery
Experts discuss alternative administration roots and why they matter.Online Exclusives Charles Sternberg, Associate Editor 04.18.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading
Aims to enable greater clarity on maximizing the therapeutic effect of Neucore’s FiXE platform as it advances clinical development.04.18.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | QA/QC
Cellares Launches Cell Q Automated cGMP QC Workcell for Cell Therapies
Aims to resolve manual QC processing bottleneck and extend IDMO capabilities from manufacturing through quality control.04.18.24
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Process Development
Kincell Bio to Acquire Imugene’s NC Mfg. Facility
Expands capacity to provide development and manufacturing support for the immunocellular therapy market.04.16.24
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
Ginkgo Bioworks Acquires AgBiome's Platform Assets
Expands unified metagenomics database for biological discovery and development.04.11.24
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Vertex Agrees to Acquire Alpine Immune Sciences for $4.9B
Alpine’s lead product, povetacicept, demonstrated best-in-class potential in patients with IgA nephropathy (IgAN).04.11.24
-
Biologics, Proteins, Vaccines | Breaking News
Soligenix Granted FDA Orphan Drug Designation for SuVax Active Ingredient
The SuVax vaccine specifically addresses the potentially lethal Sudan Virus Disease, caused by SUDV.04.11.24
-
Biologics, Proteins, Vaccines
Isolation and Characterization of Product-Related Variants in Biotherapeutics
Biotherapeutics comprise a diverse class of protein-based drugs with intricate structural and functional characteristics.04.10.24
-
Biologics, Proteins, Vaccines
Host Cell DNA Assay Re-Development and Qualification for a PEGylated Protein Drug Substance
Biologic drugs must ensure that DNA from the host cell (hc) is below a recommended limit set by the FDA.04.10.24
-
Biologics, Proteins, Vaccines | Biosimilars
Real-Time Kinetic Data in the Successful Dev of an Inhibition of Proliferation Potency Bioassay
The quantitative measurement of potency plays a critical role in biopharmaceutical development.04.10.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Batavia, Chromatan Receive NIIMBL Grant to Improve AAV Manufacturing
To integrate column-free continuous chromatography into HIP-Vax manufacturing platform.04.10.24
-
Biologics, Proteins, Vaccines | Clinical Trial Materials | Clinical Trials
Clinical Supply CDMOs Rejig Service Models
CGTs and DTP trials supercharge bespoke solutions demand.Soman Harachand, Contributing Writer 04.10.24
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
Lonza, NeuroSense Enter Alliance for ALS Candidate
Lonza will provide the development, optimization, and qualification of a method measuring biomarkers from NDEs.04.09.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.04.09.24
-
Biologics, Proteins, Vaccines | Breaking News | Trials & Filings
ViiV Healthcare Receives FDA Approval for Dovato for Adolescents
Expanded indication marks the first time an oral, two-drug, single-tablet regimen is available for adolescents between 12 & 18 living with HIV.04.08.24
-
Biologics, Proteins, Vaccines | Breaking News | Trials & Filings
BMS, 2seventy bio Win FDA Approval for Abecma in Multiple Myeloma
Expands Abecma’s indication, making it available in earlier lines of therapy.04.05.24
-
Biologics, Proteins, Vaccines | Biosimilars
Underlying Economics of Unbranded Biologics
Unbranded biologics exist is to protect the gross list price of the branded variant.Online Exclusives Dinakaran Balasubramanian, Dr. Reddy’s Laboratories 04.05.24
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Pluristyx Launches PluriFreeze Cryopreservation Media
Designed to support cell metabolism and ease pluripotent stem and other energetically active cells to and from the frozen state.04.04.24
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Ship of Theseus Taps Charles River as Manufacturing Partner
Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.04.04.24
